Cidara Therapeutics (CDTX)
NASDAQ:CDTX
Holding CDTX?
Track your performance easily

Cidara Therapeutics (CDTX) Financial Statements

718 Followers

Cidara Therapeutics Financial Overview

Cidara Therapeutics's market cap is currently ―. The company's EPS TTM is $-25.554; its P/E ratio is -0.53; Cidara Therapeutics is scheduled to report earnings on March 11, 2025, and the estimated EPS forecast is $-3.52. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Sep 23Jun 23
Income Statement-
Total Revenue-$ 302.00K$ 8.46M$ 12.72M$ 5.09M
Gross Profit-$ 302.00K$ 2.83M$ 12.72M$ 5.09M
EBIT$ -15.98M$ -91.21M$ -10.33M$ -7.94M$ -13.58M
EBITDA$ -15.64M$ -90.87M$ -10.08M$ -7.66M$ -13.18M
Net Income Common Stockholders$ -15.98M$ -91.21M$ -10.33M$ -8.17M$ -13.62M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 127.39M$ 164.37M$ 29.02M$ 48.67M$ 50.43M
Total Assets$ 162.33M$ 173.36M$ 52.72M$ 63.47M$ 67.99M
Total Debt$ 3.94M$ 4.30M$ 4.65M$ 4.36M$ 4.54M
Net Debt$ -123.44M$ -160.07M$ -24.37M$ -44.31M$ -45.89M
Total Liabilities$ 46.70M$ 42.42M$ 70.50M$ 55.43M$ 52.57M
Stockholders Equity$ 115.63M$ 130.94M$ -17.78M$ 8.04M$ 15.41M
Cash Flow-
Free Cash Flow$ -36.80M$ -103.78M$ -6.67M$ -1.76M$ 2.71M
Operating Cash Flow$ -36.70M$ -103.78M$ -6.64M$ -1.63M$ 2.82M
Investing Cash Flow$ -106.00K-$ -23.00K$ -126.00K$ -107.00K
Financing Cash Flow$ -182.00K$ 239.13M$ -93.00K-$ -261.00K
Currency in USD

Cidara Therapeutics Earnings and Revenue History

Cidara Therapeutics Debt to Assets

Cidara Therapeutics Cash Flow

Cidara Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis